[Fatal fulminant varicella-zoster virus hepatitis in a female patient with Crohn's disease treated by an anti-TNF-alpha agent].

التفاصيل البيبلوغرافية
العنوان: [Fatal fulminant varicella-zoster virus hepatitis in a female patient with Crohn's disease treated by an anti-TNF-alpha agent].
عنوان ترانسليتريتد: Hépatite fulminante fatale à virus de la varicelle-zona chez une patiente porteuse d'une maladie de Crohn traitée par anti-TNF alpha.
المؤلفون: Mériglier E; Service de réanimation médicale, CHU de Poitiers, 86021 Poitiers, France. Electronic address: etienne.meriglier@sfr.fr., Coudroy R; Service de réanimation médicale, CHU de Poitiers, 86021 Poitiers, France., Agius G; Laboratoire de virologie, CHU de Poitiers, 86021 Poitiers, France.
المصدر: Medecine et maladies infectieuses [Med Mal Infect] 2014 Oct; Vol. 44 (10), pp. 484-6. Date of Electronic Publication: 2014 Sep 26.
نوع المنشور: Case Reports; Letter
اللغة: French
بيانات الدورية: Publisher: Elsevier Country of Publication: France NLM ID: 0311416 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1769-6690 (Electronic) Linking ISSN: 0399077X NLM ISO Abbreviation: Med Mal Infect Subsets: MEDLINE
أسماء مطبوعة: Publication: Paris : Elsevier
Original Publication: Paris, Société française d'éditions médicales.
مواضيع طبية MeSH: Herpesvirus 3, Human*, Antibodies, Monoclonal, Humanized/*adverse effects , Crohn Disease/*drug therapy , Hepatitis, Viral, Human/*chemically induced, Adalimumab ; Adult ; Crohn Disease/complications ; Fatal Outcome ; Female ; Humans ; Tumor Necrosis Factor-alpha/antagonists & inhibitors
فهرسة مساهمة: Keywords: Anti-TNF alpha; Anti-TNF alpha agent; Crohn's disease; Hépatite à VZV; Maladie de Crohn; VZV hepatitis
المشرفين على المادة: 0 (Antibodies, Monoclonal, Humanized)
0 (Tumor Necrosis Factor-alpha)
FYS6T7F842 (Adalimumab)
تواريخ الأحداث: Date Created: 20140930 Date Completed: 20150921 Latest Revision: 20151119
رمز التحديث: 20221213
DOI: 10.1016/j.medmal.2014.09.002
PMID: 25263938
قاعدة البيانات: MEDLINE
الوصف
تدمد:1769-6690
DOI:10.1016/j.medmal.2014.09.002